3t Biosciences

Developer of T-cell-based cancer immunotherapies to fight cancer

placeToronto, Ontario, Canada calendar_todayFounded 2017 groups33 employees language 3tbiosciences.com

Social engagement

Social engagement: 6.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Westlake Village Biopartners.

Investor typeCountShare
Venture capital990%
Other / undisclosed110%

Hiring activity

Hires periodically

3 roles tracked across 3 of the last 12 months

7 Mar 2026 · Contract Clinical Trial Manager · Australia

4 Nov 2025 · Research Associate (Immunology)

22 Oct 2025 · immunologist

27 Aug 2025 · Sr. Scientist, Immunology

Based on job postings tracked across public sources.

Recent activity

19 Mar 2026
Recognition
2 Mar 2026
Leadership hire
Head of Clinical Operations
8 Jan 2026
Leadership hire
Chief Medical Officer
Coming soon